Liver Diseases
340
39
46
162
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Published Results
34 trials with published results (10%)
Research Maturity
162 completed trials (48% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
6.5%
22 terminated out of 340 trials
88.0%
+1.5% vs benchmark
9%
29 trials in Phase 3/4
21%
34 of 162 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 162 completed trials
Clinical Trials (340)
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment
Liver Micro Flow - MRI
RESTORE Declined Livers Study
Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Observational Pharmaco-Epidemiology Research & Analysis
Liver Function Test Abnormalities in Pediatric Type 1 Diabetes
Effect of Synapse Medicine Decision Support on Inpatient Pharmacist Efficacy and Efficiency
Assessment of Microorganisms and Host Response In Liver Diseases
RTX001 Autologous Engineered Macrophages for Liver Cirrhosis
Liver Cancer Prevention Randomized Control Trial
Implementation of a Digital Clinic for Alcohol-associated Liver Disease and Alcohol Use Disorder (DALC)
Development of a New Method for Liver Stiffness Measurement Using FibroScan
Development of a FibroScan Liver Examination Using a Single Probe
Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)
Normal Liver Stiffness by MR Elastography
Patients With Hepatocellular Carcinoma (HCC)
Early Detection of Hepatocellular Carcinoma in a High-risk Prospective Cohort (ELEGANCE)
Genetic Collection Protocol
Primary Sclerosing Cholangitis in Children